• Disclosure
  • Privacy Policy
  • DMCA Policy
  • CCPA
  • Medical Disclaimer
  • Contact
  • About
Sunday, August 14, 2022
Maryland Digital News
  • Home
  • US
  • Business
  • World
  • Baltimore
  • Columbia
  • Germantown
  • Waldorf
  • Silver Spring
  • Frederick
  • Press Releases
  • Videos
No Result
View All Result
  • Home
  • US
  • Business
  • World
  • Baltimore
  • Columbia
  • Germantown
  • Waldorf
  • Silver Spring
  • Frederick
  • Press Releases
  • Videos
No Result
View All Result
No Result
View All Result
Home Silver Spring

Strong New Evidence Suggests A Virus Triggers Multiple Sclerosis

by NewsReporter
January 13, 2022
in Silver Spring
Reading Time: 6 mins read
strong-new-evidence-suggests-a-virus-triggers-multiple-sclerosis
Share on FacebookShare on Twitter

If you were to ask any of the 1 million Americans living with multiple sclerosis, they’d probably say their disease started with changes so small they almost didn’t notice them: a wobbly step, a weakening grip, sight going soft around the edges. But MRI scans of their brains — dotted with ghostly white scars — would tell a different story.

Those scars are signs of inflammation dating back multiple years. Each spot represents a dead zone filled with mangled remains of thousands, sometimes millions, of neurons. Like city blocks going dark during a power outage, these cells blinked out one by one after an immune storm stripped off the insulating myelin sheath that helps them send and receive electrical signals. But what triggers the immune system to turn on itself is still a mystery.

Now researchers have found strong evidence that it’s an infection, specifically the Epstein-Barr virus, best known for causing mononucleosis. In a large cohort of military service members followed over many years, infection with Epstein-Barr increased the likelihood of developing multiple sclerosis, or MS, by more than 32-fold, a team of scientists led by Harvard University’s Neuroepidemiology Research Group reported in the journal Science on Thursday.

advertisement

“Our data strongly suggest Epstein-Barr virus is the leading cause of multiple sclerosis,” said Kjetil Bjornevik, a research scientist at Harvard and the study’s lead author. “It was a really dramatic increase in risk that would be very hard to explain any other way.”

More than a decade ago, his Harvard colleague, epidemiologist Alberto Ascherio had a hunch that the answer to what initiates MS might be frozen somewhere on the campus of the Walter Reed Army Institute of Research in Silver Spring, Md. Since 1985, scientists there have been collecting, screening, and storing (at 30 degrees Celsius) blood drawn from every member of the U.S. military every few years. With more than 62 million samples from over 10 million active and reserve duty members, the Department of Defense Serum Repository is the largest collection of its kind in the world.

advertisement

For biomedical researchers, the Serum Repository is their Hubble Telescope. It allows them to look not just deep into people’s bodies, but also back in time, to moments before the diseases they’re interested in took hold. That’s particularly important for MS, because it’s most often diagnosed in people in their 20s and 30s. In order to capture people prior to disease onset, you have to start sampling when they’re in their teens — like, say, when most military recruits sign up for service.

Brain inflammation is a not-uncommon side effect of viral infections — something the millions of people with long Covid are living testament to. In the early 2000s, Ascherio and others had found clues that the triggering agent for MS might be Epstein-Barr, or EBV, a particularly ubiquitous member of the herpesvirus family. The virus had been found in the demyelinated death zones of MS patients. And people with elevated levels of antibodies against EBV were more likely to be diagnosed with MS. To prove one caused the other, Ascherio, a co-author of the new paper, turned to the “experiment of nature” taking place at the Serum Repository.

Physicians who treat patients with multiple sclerosis and study the disease agreed that the work showed convincingly that EBV is both necessary for and precedes the diagnosis of MS. “This is a very intriguing article that extends our understanding of the role of EBV in MS development,” John Corboy, a neurologist and co-director of the Rocky Mountain MS Center at the University of Colorado, told STAT via email.

But, he said, it’s still too soon to say the virus alone is sufficient to cause MS. For example, the study does not explain why only a tiny minority of those infected with EBV develop MS. “It leaves many questions about pathogenesis unanswered,” Corboy wrote.

What the study really adds is showing in a time-resolved way the sequence of events leading up to an MS diagnosis, said Michael Wilson, a neurologist at the University of California, San Francisco, who specializes in poorly understood neuroinflammatory disorders.

The Harvard team didn’t just look for signs of the EBV virus itself or antibodies against it. They also went fishing for something called neurofilament light chain, or NfL. When under attack, neurons shed these threadlike pieces of themselves, and some of them wash into the cerebrospinal fluid and out into the bloodstream. Studies have shown that a rise in NfL levels precedes onset of MS by a couple of years. The new research found this marker of neurodegeneration didn’t increase until after infection. That argues against reverse pathology — where MS impacts the immune system to make it more susceptible to EBV infection.

“That lends this study additional weight,” said Wilson. “Not only were soldiers not diagnosed with MS at the beginning of the study, but their NfL levels were also negligible, so they probably didn’t have a case of MS smoldering under the radar.”

The study doesn’t explain how exactly EBV might trigger multiple sclerosis. Other research groups have speculated that the virus might carry proteins that resemble myelin, a case of molecular mimicry that could trigger an autoimmune reaction. Others have proposed that because EBV often takes up long-term residency in B cells, the latent infection may somehow transform these immune cells, making them pathogenic.

“It’s long been a theory that MS is a multifactorial disease,” said Wilson. Studies have shown that certain genes can heighten the risk of developing it. So can not getting enough vitamin D. Combined with an environmental exposure, like a viral infection, these factors might be enough to trigger the disease. “EBV probably isn’t the whole story, but this study helps show it’s clearly part of it. The exciting thing is that it’s a modifiable part of the story.”

We’re all stuck with the DNA we inherited from our parents. But EBV is a virus, so our immune systems can be trained to prevent it from infecting us. Currently there is no vaccine against EBV; efforts to develop one have historically been hindered by technical hurdles and lack of investment because the virus isn’t initially life-threatening. But studies like this suggest we should be pushing harder on developing a vaccine against EBV, said Wilson. Besides MS, the virus has also been linked to a variety of cancers and other autoimmune diseases such as lupus.

“Understanding the detailed mechanism of how EBV triggers MS is more of an academic question,” said Wilson. “For a public vaccination campaign, we just have to show that it reduces cases of MS, even if we don’t understand exactly how it’s happening.”

There are precedents for such a campaign. In 2006, regulators approved a vaccine to prevent spread of four strains of human papillomavirus, or HPV, which raise risks of developing cervical cancers that kill thousands of women in the U.S. each year. Although Americans were slow to get immunized, uptake in the U.K. was sky-high. A recent analysis found the vaccines have already nearly eliminated cervical cancer in young women there.

“If EBV is causing MS then this could shift the focus of research into trying to find a cure for MS as well as motivate vaccine development,” said Bjorevik. The study might also shift research priorities for other neurological conditions. For years, scientists have found evidence that Alzheimer’s disease might be driven by inflammation triggered by viral infections, including other herpes viruses. But these outsiders’ research has repeatedly been met with ridicule, their projects left unfunded and their hypotheses unexplored.

“Our findings are very specific for MS, but we expect it may spark interest in reexamining infectious causes of other diseases,” said Bjorevik.

Read More Here

Related Posts

5-things-to-know-today,-april-14,-in-montgomery-county

5 Things To Know Today, April 14, In Montgomery County

by NewsReporter
April 14, 2022
0

It’s Thursday, April 14 and here are five things to know in Montgomery County. 1. State of the County: Montgomery County Executive Marc Elrich will deliver his 2022 “State of the County” address at noon at the Silver Spring Civic Building. This will be County Executive Elrich’s first in-person State...

senator-demands-answers-from-fda

Senator Demands Answers From FDA

by NewsReporter
April 13, 2022
0

U.S. Sen. Patty Murray (D-WA), Chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, sent a letter to Food and Drug Administration (FDA) Commissioner Robert M. Califf urging answers and immediate action following a Politico report that lays bare a culture of delay and inaction in the agency’s...

what-le-pen-would-(and-wouldn’t)-do-if-she-beats-macron

What Le Pen Would (And Wouldn’t) Do If She Beats Macron

by NewsReporter
April 12, 2022
0

FRENCH TWIST — If Marine Le Pen becomes the next president of France, the European Union won’t collapse. Neither will the euro. There isn’t going to be a Frexit.But the far-right politician is a genuine threat to the liberal Western order. Here’s why you should worry she could win France’s...

ville-valo,-ex-him-lead-singer-announces-2023-us-tour

Ville Valo, Ex-HIM Lead Singer Announces 2023 US Tour

by NewsReporter
April 11, 2022
0

(CelebrityAccess) – Former HIM frontman Ville Valo (VV) has announced a 2023 tour of the United States supporting his album Neon Noir. The Finnish singer/songwriter has confirmed his next album will be released in early 2023. In addition to the announced US dates, VV will also be hitting Europe and...

Maryland Digital News

© 2021 Maryland Digital News

Navigate Site

  • Disclosure
  • Privacy Policy
  • DMCA Policy
  • CCPA
  • Medical Disclaimer
  • Contact
  • About

Follow Us

No Result
View All Result
  • Home
  • About
  • DMCA Policy
  • Medical Disclaimer
  • Privacy Policy
  • Disclosure
  • CCPA
  • Terms of Use

© 2021 Maryland Digital News

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT